Citation:Claringbold PG, Brayshaw PA, Price RA, Turner JH 2011

From Cancer Guidelines Wiki


Claringbold PG, Brayshaw PA, Price RA, Turner JH. Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2011 Feb;38(2):302-11 Abstract available at

Critical appraisals

Compare quality appraisals for each clinical question

Cited by

  1. NETs guidelines/Radionuclide Therapy